Pantoprazole sodium delayed-release NDC 70756-018

NDC codes

FDA NDC Directory

Product NDC (as listed)70756-018Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70756-0018Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
70756-018-51	70756001851	500 TABLET in 1 BOTTLE (70756-018-51)Marketed from Apr 25, 2024
70756-018-90	70756001890	90 TABLET in 1 BOTTLE (70756-018-90)Marketed from Apr 25, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Pantoprazole sodium delayed-release
Generic name (nonproprietary): pantoprazole sodium delayed-release
Active ingredients: Pantoprazole sodium — 20 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Lifestar Pharma LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215880
Marketing start: Apr 25, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Proton Pump Inhibitors (Mechanism)
Identifiers: Product ID 70756-018_2c507c43-c033-4b6e-b954-f0f2fb617289SPL ID 2c507c43-c033-4b6e-b954-f0f2fb617289SPL set ID 0502f935-af7a-4f1e-8c3e-29e20647c885RxCUI 251872, 314200UNII 6871619Q5XUPC 0370756019121, 0370756019909
Pharmacologic class: Proton Pump Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470756001851 followed by a unit qualifier and the quantity

Package 70756-0018-51. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 8, 2025.

Indications (excerpt from the label)

Pantoprazole sodium delayed-release tablets are indicated for: Pantoprazole sodium is a proton pump inhibitor (PPI) indicated for the following: Short-Term Treatment of Erosive Esophagitis Associated with Gastroesophageal Reflux Disease (GERD) ( 1.1 ) Maintenance of Healing of Erosive Esophagitis ( 1.2 ) Pathological Hypersecretory Conditions Including Zollinger-Ellison (ZE) Syndrome ( 1.3 ) 1.1 Short-Term Treatment of Erosive Esophagitis Associated With Gastroesophageal Reflux Disease (GERD) Pantoprazole sodium is indicated in adults and pediatric patients five years of age and older for the short-term treatment (up to 8 weeks) in the healing and symptomatic relief of erosive esophagitis (E…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 215880

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 215880
Product	Strength	Form · route	Labeler	Product NDC
Pantoprazole sodium delayed-release	Pantoprazole sodium 40 mg/1	TabletOral	Lifestar Pharma LLC	70756-019